Pharmacotherapy and Risk of Suicidal Behaviors among Patients with Bipolar Disorder [1] (multiple letters)

JAMA

Volumn 291, Issue 8, 2004, Pages 939-940

  Bowden, Charles ^a   Fawcett, Jan ^b   Yerevanian, Boghos I ^c   Koek, Ralph J ^c   Feusner, Jamie D ^c   Goodwin, Frederick K ^d   Simon, Greg ^e   Revicki, Dennis ^f   Hunkeler, Enid ^g   Fireman, Bruce ^g   Lee, Janelle ^g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

^f UNITED BIOSOURCE CORPORATION   (United States)

^g DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROATE SEMISODIUM; LITHIUM DERIVATIVE; TRANQUILIZER; VALPROIC ACID; ANTIDEPRESSANT AGENT;

ANXIETY; BIPOLAR DISORDER; DEPRESSION; HUMAN; LETTER; MOOD DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; EPIDEMIOLOGY; NOTE; PSYCHOLOGICAL ASPECT; SUICIDE; DRUG COMBINATION; PATIENT COMPLIANCE; RISK;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; LITHIUM COMPOUNDS; RISK FACTORS; SUICIDE; VALPROIC ACID; ANTIDEPRESSIVE AGENTS; DRUG THERAPY, COMBINATION; PATIENT COMPLIANCE; RISK;

EID: 18144451784     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.8.939-a     Document Type: Letter

References (0)